People

Rosemary Akhurst, PhD studies the role of signaling molecules and genetic modifiers in vasculogenesis, the formation of the vascular network during development.

Tamara Alliston, PhD studies the mechanobiologic mechanisms supporting skeletal health and driving arthritis, osteoporosis, and bone fragility.

Arturo Alvarez-Buylla, PhD studies the origin, migration and functional contribution of neural stem cells born in the adult brain. He has initiated studies exploring progenitor cell transplants for the treatment of Parkinson’s disease and epilepsy.

Mark Anderson, MD, PhD is the Director of the Diabetes Center. He studies immune tolerance and the role of the thymus in type 1 diabetes and autoimmune disease.

Serine Avagyan, MD, PhD studies blood stem cell clonality and clonal hematopoiesis.

Allan Balmain, PhD focuses on the role of stem cells in skin and lung cancer. His goal is to identify the critical tumor-originating cells and the mechanisms by which they become transformed, which will aid in both stem cell therapy and cancer therapy.

Scott Baraban, PhD studies pediatric malformation-associated epilepsies in genetic mouse models to explore how seizures develop. He also researches the potential of embryonic progenitor cells to inhibit epilepsy following transplantation.

Mitchel Berger, MD studies the correlative biology and outcome of patients with both low-grade and high-grade gliomas.

Sigurd Berven, MD is an orthopedic spine surgeon who researches the therapeutic potential of mesenchymal stem cells in an animal model of disc degeneration.

Daniel Bikle, MD, PhD studies the hormonal regulation of calcium metabolism in the formation, differentiation and repair of bone and skin tissue, as well as in skin cancer development.

Robert Blelloch, MD, PhD studies gene regulation of pluripotent stem cells, early development, and cancer.

Benoit Bruneau, PhD is the Director of the Gladstone Institute of Cardiovascular Disease. He studies the transcriptional and epigenetic regulation of cardiogenesis.